Your browser doesn't support javascript.
loading
Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses.
Muir, Roshell; Metcalf, Talibah; Fourati, Slim; Bartsch, Yannic; Kyosiimire-Lugemwa, Jacqueline; Canderan, Glenda; Alter, Galit; Muyanja, Enoch; Okech, Brenda; Namatovu, Teddy; Namara, Irene; Namuniina, Annemarie; Ssetaala, Ali; Mpendo, Juliet; Nanvubya, Annet; Kitandwe, Paul Kato; Bagaya, Bernard S; Kiwanuka, Noah; Nassuna, Jacent; Biribawa, Victoria Menya; Elliott, Alison M; de Dood, Claudia J; Senyonga, William; Balungi, Priscilla; Kaleebu, Pontiano; Mayanja, Yunia; Odongo, Matthew; Connors, Jennifer; Fast, Pat; Price, Matt A; Corstjens, Paul L A M; van Dam, Govert J; Kamali, Anatoli; Sekaly, Rafick Pierre; Haddad, Elias K.
Afiliação
  • Muir R; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.
  • Metcalf T; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.
  • Fourati S; PATRU, School of Medicine, Emory University, Atlanta, Georgia, United States of America.
  • Bartsch Y; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America.
  • Kyosiimire-Lugemwa J; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • Canderan G; Department of Medicine, Allergy and Immunology, University of Virginia, Charlottesville, Virginia, United States of America.
  • Alter G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America.
  • Muyanja E; PATRU, School of Medicine, Emory University, Atlanta, Georgia, United States of America.
  • Okech B; UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
  • Namatovu T; UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
  • Namara I; UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
  • Namuniina A; UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
  • Ssetaala A; UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
  • Mpendo J; UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
  • Nanvubya A; UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
  • Kitandwe PK; UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
  • Bagaya BS; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • Kiwanuka N; Department of Immunology and Molecular Biology, School of Biomedical Sciences, Makerere University, College of Health Sciences, Kampala, Uganda.
  • Nassuna J; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University, College of Health Sciences, Kampala, Uganda.
  • Biribawa VM; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University, College of Health Sciences, Kampala, Uganda.
  • Elliott AM; UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
  • de Dood CJ; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • Senyonga W; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Balungi P; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.
  • Kaleebu P; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • Mayanja Y; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • Odongo M; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • Connors J; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • Fast P; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • Price MA; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.
  • Corstjens PLAM; International AIDS Vaccine Initiative, New York, New York, United States of America.
  • van Dam GJ; Pediatric Infectious Diseases, Stanford University School of Medicine, Palo Alto, California, United States of America.
  • Kamali A; International AIDS Vaccine Initiative, New York, New York, United States of America.
  • Sekaly RP; Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California, United States of America.
  • Haddad EK; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.
PLoS Negl Trop Dis ; 17(7): e0011089, 2023 07.
Article em En | MEDLINE | ID: mdl-37406029

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquistossomose mansoni Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquistossomose mansoni Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article